5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer

The goal of this study is to evaluate 5 days vs. 9 days of whole breast radiation.

Trial Details

NCT ID
NCT06961955
Phase
PHASE2
Sponsor
University of Utah
Status
RECRUITING
Cancer Type
Lobular Carcinoma Breast Cancer
Interventions
  • Radiation Therapy
Locations (sample)
  • Salt Lake City, Utah, United States|40.76078,-111.89105

Key Eligibility Criteria

  • Female participant aged ≥ 18 years.
  • -Participants must have at least one of the following risk factors:
  • Grade 3 invasive histology
  • Estrogen receptor positivity less than 5%

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lobular Carcinoma Breast Cancer Trials on Trialify →